Woodline Partners LP Exelixis, Inc. Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 987,094 shares of EXEL stock, worth $25.9 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
987,094
Previous 987,094
-0.0%
Holding current value
$25.9 Million
Previous $23.4 Million
5.31%
% of portfolio
0.22%
Previous 0.22%
Shares
7 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$879 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$778 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$711 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$398 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$331 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.44B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...